Category Specific RSS

Satire

Star shares tank as Australians shocked that casinos don’t just give away free money

Amid the regulatory crackdown into casino operations which this week sent Star Entertainment Group (ASX: SGE) into a nosedive, Australians are in disbelief that casinos have actual business plans to occasionally win from games played by their patrons seeking a quick buck. 

The revelations come amid confirmation that Australian regulators were looking into Star’s casinos in New South Wales and Queensland, suspecting links to criminal organisations that use casinos as a tool for money laundering. 

SGE shares dropped 23% to $3.30 after the news was brought to light. Residents were notably shaken by the allegations which come after a 2-year enquiry into rival casino operator Crown Resorts (ASX: CWN) whose tactics to entice people to gamble were seemingly unfathomable for a company with a mandate to make money for its stakeholders. 

“It was alarming to learn that The Star can be used to launder money,” said Sydney resident Martina Martinez. 

“I had always assumed that only good-standing citizens frequented casinos as a means of entertainment. How could anyone have known that opportunities to get rich quickly could be manipulated with ill-intent?” 

With this fresh information that Star may be laundering money through their casino operations, Martinez has vowed to just throw her annual gambling budget of $100 directly in the trash to limit her involvement in organised crime, and get the same result. 

Elias Pivep

Failed stand-up comic who now gets his kicks from Simpsons business memes.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago